Physician profile
Leonel Martinez
NPI 1598915217
$5,378.03
in general payments reported to CMS, 2019-2025
18 companies · $1,783 in 2025
The $1,783 reported for 2025 was more than what 88% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,793 · 2020: $54.34 · 2021: $131 · 2022: $213 · 2023: $71.13 · 2024: $333 · 2025: $1,783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,334 · Travel and Lodging: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,333.65 |
| Travel and Lodging | $853.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $2,444.11 | 2019-2022 | |
| Aerin Medical INC. | $1,678.48 | 2019-2025 | |
| Medtronic, INC. | $224.71 | 2024-2025 | Propel |
| Stryker Corporation | $223.73 | 2019-2021 | |
| Glaxosmithkline, LLC. | $157.71 | 2022-2025 | Nucala |
| Smith+Nephew, INC. | $103.65 | 2019-2025 | Tula, Halo, Ent Sinus |
| Regeneron Healthcare Solutions, INC. | $97.21 | 2019-2025 | Dupixent |
| Alk-Abello, INC | $96.20 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $84.05 | 2019 | |
| Genzyme Corporation | $69.19 | 2021-2022 | |
| Optinose US, INC. | $60.51 | 2019-2023 | |
| Titan Surgical Group, LLC | $27.08 | 2022 | |
| Inspire Medical Systems, INC. | $26.43 | 2024 | Inspire |
| Integra Lifesciences Corporation | $20.82 | 2024 | Acclarent Aera |
| Takeda Pharmaceuticals U.S.A., INC. | $18.52 | 2025 | Eohilia |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $17.61 | 2023 | Ryaltris |
| Covidien Lp | $15.82 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonel Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.